ArticleJournal of animal science2026
Laying hen responses to balanced protein reduction on performance, egg quality, nitrogen balance, and fat and mineral utilization.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effect of graded reductions in balanced crude protein (CP) on hen productive performance, egg quality, nitrogen balance, abdominal fat deposition, tibia traits, and relative economic outcomes from 26 to 44 wk of age (WOA) was investigated. A total of 252 26-wk-old Hy-Line Brown hens were housed in enriched cages (seven birds/cage) and randomly allocated to one of four different dietary CP levels of iso-energetic diets with nine replicates per treatment. The trial was conducted over two phases of 26 to 34 and 36 to 44 WOA. Diets included a high-protein (HP; 18.0% and 17.0% CP in Phases 1 and 2), medium-protein (MP), low-protein (LP), and very low-protein (VLP) series, representing stepwise reductions of 0.50, 1.00, and 1.50 percentage points relative to HP. Limiting amino acids (AA; lysine, methionine, and threonine) were supplemented to ensure balanced AA profiles. Collected data were analyzed using the general linear model (GLM) procedure for one-way ANOVA; statistical significance was set at P < 0.05, and trends were noted at 0.05 < P < 0.10. Balanced protein reduction tended to improve abdominal fat contents (2.66% to 2.85%; P = 0.059), but reduce body weight gain (141.66 to 95.66 g; P = 0.089), particularly with the VLP diet. Across 26 to 44 WOA, graded CP reduction lowered egg weight (60.36 to 59.40 g; P < 0.05) and feed conversion efficiency (1.93 to 1.97 g feed/g egg; P < 0.05); and tended to reduce egg mass (57.02 to 55.11 g/hen/day; P = 0.080), particularly in the VLP group. As to egg quality, Haugh units were higher (P < 0.05) with HP and MP diets (94.60 and 94.30) than LP and VLP diets (93.66 and 93.04) across 26-44 WOA. In contrast, LP and VLP diets tended to improve yolk color (8.38 to 8.49; P = 0.076) and egg-breaking strength (5.39 to 5.51 kg; P = 0.058) across 26-44 WOA. Dietary CP reduction linearly reduced nitrogen consumed and excreted by more than 10% (P < 0.05). Tibia-breaking strength tended to decline with dietary CP reduction (P = 0.094), decreasing from 27.62 kg in HP to 25.54-25.68 kg in the LP and VLP diets. Economically, reduced CP lowered egg income (P < 0.05) at weeks 34 and 44 (2.00 to 1.77$; 1.96 to 1.89$, respectively); and feed costs at week 34 only (0.54 to 0.52$; P = 0.088), but profit margins remained unaffected (P > 0.10). Conclusively, these results confirm the effectiveness of balanced dietary protein reduction in maintaining egg production rate and most egg quality traits while reducing nitrogen excreted and feed costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.